Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights

by Shihan Xu, Shihan Xu, Shihan Xu, Tingwei Zhang, Tingwei Zhang, Tingwei Zhang, Zhengguo Cao, Zhengguo Cao, Wenjie Zhong, Wenjie Zhong, Wenjie Zhong, Chuangwei Zhang, Chuangwei Zhang, Chuangwei Zhang, Han Li, Han Li, Han Li, Jinlin Song, Jinlin Song, Jinlin Song
Published 2021-03-01